References
- Djurkovic-Djakovic O, Milenkovic V, Nikolic A, Bobic B, Grujic J. 2002. Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii. J Antimicrob Chemother 50(6): 981-987. https://doi.org/10.1093/jac/dkf251
- Ferreira R, Oliveira AB, Ribeiro MF, Tafuri WL, Vitor RW. 2006. Toxoplasma gondii: In vitro and in vivo activities of the hydroxy naphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1, 4-naphthoquinone alone or combined with sulphadiazine. Exp Parasitol 113: 125-129. https://doi.org/10.1016/j.exppara.2005.12.006
- Hoffman SL, Subramanian GM, Collins FH, Venter C. 2000. Plasmodium, human and anopheles genomics and malaria. Nature 415: 702-709.
- Kim HK, Jiang JH, Lee DH, Kim HS, Park H. 2008. Anti-Toxoplasmosis Effect of Citrus Unshiu Markovich against Toxoplasma Gondii. Korean J Oriental Physiology & Pathology 22(1): 96-99.
- Lee DC, Ha MS, Chang MH, Choi WS. 1999. A case of comgenital Toxoplasmosis in the Neonate. J Korean Ophthalmol Soc 40(5): 247-252.
- Park JY, Kim SO, Kim JS. 2007. Congenital toxoplasmasis: a case report. J Korean Acad Pediatr Dent 34(3): 526-531.
- Petersen E. 2007. Toxoplasmosis. Seminars in Fetal & Neonatal Medicine 12: 214-223. https://doi.org/10.1016/j.siny.2007.01.011
- Song HO, Ahn MH, Ryu JS, Min DY, Joo KH, Lee YH. 2004. Influence of calcium ion on host cell invasion and intracellular replication by Toxoplasma gondii. Korean J Parasitol 42: 185-193. https://doi.org/10.3347/kjp.2004.42.4.185
- Tenter AM, Heckeroth AR, Weis, LM. 2000. Toxoplasma gondii: from animals to humans. International Journal for Parasitology 30: 1217-1258. https://doi.org/10.1016/S0020-7519(00)00124-7